BioCentury
ARTICLE | Company News

Boehringer Ingelheim sales and marketing update

September 28, 2015 7:00 AM UTC

The U.K.’s NICE issued preliminary draft guidance recommending Ofev nintedanib from Boehringer to treat idiopathic pulmonary fibrosis (IPF) -- its approved indication. The recommendation is contingen...